Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hippo pathway deficiency reverses systolic heart failure post-infarction

Hippo pathway deficiency reverses systolic heart failure post-infarction

US Patent 11944671 · Granted Apr 2, 2024

Estimated economic value: $12,716,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hippo and dystrophin complex signaling in cardiomyocyte renewal2025
Portable speaker with integrated wireless transmitter2025
Hippo regulation of cardiac vascularity, fibrosis, and inflammation2025
Dominant active yap, a hippo effector, induces chromatin accessibility and cardi2024
Dominant active yap, a hippo effector, induces chromatin accessibility and cardi2024
Hippo and dystrophin complex signaling in cardiomyocyte renewal2024
Hippo and dystrophin complex signaling in cardiomyocyte renewal2024
Portable speaker with integrated wireless transmitter2024
Portable speaker with dynamic display characteristics2023
Dominant active yap, a hippo effector, induces chromatin accessibility and cardi2022
Dominant active yap, a hippo effector, induces chromatin accessibility and cardi2022
Hippo and dystrophin complex signaling in cardiomyocyte renewal2022